Quarterly report pursuant to Section 13 or 15(d)

Schedule of Incurred Expenses of Minority Shareholders (Details)

v3.22.2.2
Schedule of Incurred Expenses of Minority Shareholders (Details) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Jun. 30, 2022
Jun. 30, 2021
Cost of Revenue        
CWRU – Royalty Fee $ 369
Research and Development Expense        
Total Related Party Expenses 543 439 882 549
General and Administrative Expense [Member]        
General and Administrative Expense        
Stock-based compensation expense – Physician Inventors’ stock options 272 273 544 364
Research and Development Expense [Member]        
General and Administrative Expense        
Stock-based compensation expense – Physician Inventors’ stock options 52 52 99 58
Research and Development Expense        
Amended CWRU License Agreement - reimbursement of patent legal fees 209 113 209 113
Fees - Physician Inventors’ consulting agreements 10 1 18 14
Sponsored research agreement 3
Royalty [Member]        
Cost of Revenue        
CWRU – Royalty Fee $ 9